EUVIMEDObjevte EUVIMED
Multizentrische StudieBeobachtungsstudie

Impact of Preprocedural Anemia on Outcomes in Patients With Tricuspid Regurgitation Undergoing Transcatheter Edge‐to‐Edge Repair: Insights From the TRISPA Registry

Julio Echarte-Morales iD, Andrea Ruberti iD, Laura Sanchis iD, Dabit Arzamendi, Vanessa Moñivas, Fernando Chinchilla Carrasco-Chinchilla, Manuel Pan, Luis Nombela-Franco, Isaac Pascual, Tomás Benito-González, Ruth Pérez, Iván Gómez-Blázquez and 16 more

Catheterization and Cardiovascular Interventions · 2026-03 · 107 (4) · 916-924

DOI: 10.1002/ccd.70408 ↗

At a glance

Multizentrische Studie in Catheterization and Cardiovascular Interventions, published online on 2025-12-15. Written by Julio Echarte-Morales and 27 co-authors. Institution: Department of Cardiology, University Hospital Alvaro Cunqueiro, Vigo, Spain. Major MEDLINE topics: Tricuspid Valve Insufficiency, Anemia, Tricuspid Valve, Cardiac Catheterization. 22 references. Funded by: The authors received no specific funding for this work..

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Tricuspid transcatheter edge‐to‐edge repair (T‐TEER) is an established treatment for tricuspid regurgitation (TR) in patients at high surgical risk. Although anemia is a well‐established predictor of poor outcomes in other transcatheter valvular interventions, its role in the tricuspid field remains poorly characterized.

Aims

To evaluate the clinical impact of anemia in a cohort of patients undergoing T‐TEER.

Methods

A total of 487 patients undergoing T‐TEER at 15 centers between 2020 and 2025 were included. Anemia was defined as a hemoglobin level < 13 g/dL in men and < 12 g/dL in women. The primary outcome was the composite of all‐cause mortality and heart failure hospitalization (HFH) at 2‐year follow‐up, with each component also evaluated separately as secondary outcomes.

Results

Anemia was present in 174 patients (35.7%). Compared to those without anemia, patients with baseline anemia had a higher burden of baseline comorbidities, as well as more frequent right ventricular remodeling and tricuspid annular dilatation. Rates of in‐hospital clinical complications were similar between groups ( p = 0.696), but patients with anemia had higher rates of residual TR ≥ 3+ ( p = 0.038). The composite endpoint at 2 years (49% vs. 12%, p < 0.001), as well as all‐cause mortality (26% vs. 9%) and HFH (31% vs. 13%), were significantly higher in anemic patients. In the multivariate analysis, anemia was an independent predictor of all‐cause mortality at follow‐up (hazard ratio 3.03 [1.30–7.96]; p = 0.01).

Conclusions

Baseline anemia is common among patients undergoing T‐TEER and is associated with increased mortality and higher TR residual degree.

Subjects

MeSH terms (MEDLINE)

Tricuspid Valve InsufficiencyAnemiaTricuspid ValveCardiac CatheterizationHeart Valve Prosthesis ImplantationHumansMaleFemaleRegistriesTreatment OutcomeTime FactorsRisk FactorsAgedRisk AssessmentAged, 80 and overHeart FailureHemoglobinsBiomarkersUnited StatesRecovery of FunctionRetrospective StudiesMiddle Aged

Author keywords

anemiatricuspid regurgitationtricuspid transcatheter edge‐to‐edge repair

Substances

HemoglobinsBiomarkers

Authors and institutions

  • Department of Cardiology, University Hospital Alvaro Cunqueiro, Vigo, Spain.
  • Cardiovascular Research Group, Department of Cardiology, University Hospital Alvaro Cunqueiro, Fundación Biomédica Galicia Sur, Servizo Galego de Saude, University of Vigo, Vigo, Spain.
  • Department of Cardiology, Cardiovascular Institute, Hospital Clínic, Barcelona, Spain.
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
  • Division of Interventional Cardiology, Hospital de la Santa Creu i Sant Pau, Universitat Autónoma de Barcelona, Barcelona, Spain.

ORCID profiles: Julio Echarte-Morales, Andrea Ruberti, Laura Sanchis, Ignacio J Amat-Santos, Chi Hion Li, Pablo Avanzas, Rodrigo Estévez-Loureiro

Funding

  • The authors received no specific funding for this work.

Cite

APA

Echarte-Morales, J., Ruberti, A., Sanchis, L., Arzamendi, D., Moñivas, V., Carrasco-Chinchilla, F. C., Pan, M., Nombela-Franco, L., Pascual, I., Benito-González, T., Pérez, R., Gómez-Blázquez, I., Amat-Santos, I. J., Cruz-González, I., Sánchez-Recalde, Á., Álvarez, A. B. C., Barreiro-Pérez, M., Umanzor, E. F., Li, C. H., …, & Estévez-Loureiro, R. (2026). Impact of Preprocedural Anemia on Outcomes in Patients With Tricuspid Regurgitation Undergoing Transcatheter Edge‐to‐Edge Repair: Insights From the TRISPA Registry. Catheterization and Cardiovascular Interventions, 107(4), 916-924. https://doi.org/10.1002/ccd.70408

Vancouver

Echarte-Morales J, Ruberti A, Sanchis L, Arzamendi D, Moñivas V, Carrasco-Chinchilla FC, et al. Impact of Preprocedural Anemia on Outcomes in Patients With Tricuspid Regurgitation Undergoing Transcatheter Edge‐to‐Edge Repair: Insights From the TRISPA Registry. Catheterization and Cardiovascular Interventions. 2026;107(4):916-924. doi:10.1002/ccd.70408

BibTeX
@article{EcharteMorales2026,
  author = {Echarte-Morales, Julio and Ruberti, Andrea and Sanchis, Laura and Arzamendi, Dabit and Moñivas, Vanessa and Carrasco-Chinchilla, Fernando Chinchilla and Pan, Manuel and Nombela-Franco, Luis and Pascual, Isaac and Benito-González, Tomás and Pérez, Ruth and Gómez-Blázquez, Iván and Amat-Santos, Ignacio J and Cruz-González, Ignacio and Sánchez-Recalde, Ángel and Álvarez, Ana Belén Cid and Barreiro-Pérez, Manuel and Umanzor, Eduardo Flores and Li, Chi Hion and Trigo, Maria Del and Martínez-Carmona, José David and Mesa, Dolores and Jiménez, Pilar and Cepas-Guillén, Pedro and Avanzas, Pablo and Fernandez-Vázquez, Felipe and Freixa, Xavier and Estévez-Loureiro, Rodrigo},
  title = {Impact of Preprocedural Anemia on Outcomes in Patients With Tricuspid Regurgitation Undergoing Transcatheter Edge‐to‐Edge Repair: Insights From the TRISPA Registry},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  volume = {107},
  number = {4},
  pages = {916--924},
  doi = {10.1002/ccd.70408}
}
Start for free →